Status:
ACTIVE_NOT_RECRUITING
Comprehensive Assessment on Diagnostic and Prognostic Performance of Coronary Physiological Indices
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-99 years
Brief Summary
The objective of the Zhongshan Hospital CONCORDE Registry is to evaluate utility, diagnostic value, and clinical outcomes of coronary physiological indices in an all-comers population of patients with...
Detailed Description
CONCORDE registry offers a comprehensive pressure and/or flow measurements, as well as angiography-derived functional assessment of coronary. Patient treatment was at the operator's discretion at the ...
Eligibility Criteria
Inclusion
- suspected coronary artery disease
- referred to invasive coronary angiography
Exclusion
- hemodynamic instability
Key Trial Info
Start Date :
December 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06127420
Start Date
December 6 2023
End Date
November 1 2024
Last Update
May 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Hospital
Shanghai, Shanghai Municipality, China, 200000